{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:13:50Z","timestamp":1771870430004,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T00:00:00Z","timestamp":1235606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2369-10-6","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T19:14:24Z","timestamp":1235675664000},"source":"Crossref","is-referenced-by-count":27,"title":["The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data"],"prefix":"10.1186","volume":"10","author":[{"given":"Victor E","family":"Pollak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Satwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,26]]},"reference":[{"key":"115_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998, 339: 584-590. 10.1056\/NEJM199808273390903.","journal-title":"N Engl J Med"},{"key":"115_CR2","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia. N Engl J Med. 2006, 355: 2071-2084. 10.1056\/NEJMoa062276.","journal-title":"N Engl J Med"},{"key":"115_CR3","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. N Engl J Med. 2006, 355: 2085-2098. 10.1056\/NEJMoa065485.","journal-title":"N Engl J Med"},{"key":"115_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev.nu.10.070190.001025","volume":"10","author":"RD Baynes","year":"1990","unstructured":"Baynes RD, Bothwell TH: Iron deficiency. Annu Rev Nutr. 1990, 10: 133-148. 10.1146\/annurev.nu.10.070190.001025.","journal-title":"Annu Rev Nutr"},{"key":"115_CR5","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood.V92.8.2934","volume":"92","author":"P Suominen","year":"1998","unstructured":"Suominen P, Punnonen K, Rajam\u00e4ki A, Irjala K: Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998, 92: 2934-2939.","journal-title":"Blood"},{"key":"115_CR6","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1097\/01.ASN.0000034200.82278.DC","volume":"13","author":"CY Hsu","year":"2002","unstructured":"Hsu CY, McCulloch CE, Curhan GC: Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol. 2002, 13: 2783-2786. 10.1097\/01.ASN.0000034200.82278.DC.","journal-title":"J Am Soc Nephrol"},{"key":"115_CR7","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","volume":"68","author":"DB Van Wyck","year":"2005","unstructured":"Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S: A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int. 2005, 68: 2846-2856. 10.1111\/j.1523-1755.2005.00758.x.","journal-title":"Kidney Int"},{"key":"115_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ndt\/gfi087","volume":"21","author":"G Mircescu","year":"2006","unstructured":"Mircescu G, G\u00e2rneata L, Capusa C, Ursea N: Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant. 2006, 21: 120-124. 10.1093\/ndt\/gfi087.","journal-title":"Nephrol Dial Transplant"},{"key":"115_CR9","first-page":"161","volume":"19","author":"L Gotloib","year":"2006","unstructured":"Gotloib L, Silverberg D, Fudin R, Shostak A: Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol. 2006, 19: 161-167.","journal-title":"J Nephrol"},{"key":"115_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2215\/CJN.00480107","volume":"3","author":"IC Macdougall","year":"2008","unstructured":"Macdougall IC, Walker R, Provenzano R, de Alvaro F, Locay HR, Nader PC, Locatelli F, Dougherty FC, Beyer U, ARCTOS Study Investigators: C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Clin J Am Soc Nephrol. 2008, 3: 337-347. 10.2215\/CJN.00480107.","journal-title":"Clin J Am Soc Nephrol"},{"key":"115_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2215\/CJN.01670408","volume":"4","author":"S Fishbane","year":"2009","unstructured":"Fishbane S, Pollack S, Feldman HI, Joffe MM: Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004. Clin J Am Soc Nephrol. 2009, 4: 57-61. 10.2215\/CJN.01670408.","journal-title":"Clin J Am Soc Nephrol"},{"key":"115_CR12","first-page":"3","volume":"18","author":"JW Eschbach","year":"1991","unstructured":"Eschbach JW: Erythropoietin 1991 \u2013 an overview. Am J Kidney Dis. 1991, 18: 3-9.","journal-title":"Am J Kidney Dis"},{"key":"115_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/ajkd.2001.22433","volume":"37","author":"K Kalantar-Zadeh","year":"2001","unstructured":"Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001, 37: 564-572.","journal-title":"Am J Kidney Dis"},{"key":"115_CR14","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002, 39: S1-246."},{"key":"115_CR15","doi-asserted-by":"crossref","unstructured":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006, 47: S11-145. 10.1053\/j.ajkd.2006.03.010.","DOI":"10.1053\/j.ajkd.2006.03.010"},{"key":"115_CR16","volume-title":"Anaemia management in people with chronic kidney disease","author":"NICE","year":"2006","unstructured":"NICE: Anaemia management in people with chronic kidney disease. Anaemia management in people with chronic kidney disease. 2006, [ http:\/\/www.nice.org.uk\/page.aspx?o=CG39Implementationadvice ]"},{"key":"115_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6947-7-38","volume":"7","author":"VE Pollak","year":"2007","unstructured":"Pollak VE, Lorch JA: Effect of electronic patient record use on mortality in End Stage Renal Disease, a model chronic disease: retrospective analysis of 9 years of prospectively collected data. BMC Med Inform Decis Mak. 2007, 7: 38-10.1186\/1472-6947-7-38.","journal-title":"BMC Med Inform Decis Mak"},{"key":"115_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. Am Stat Assoc. 1958, 53: 457-481. 10.2307\/2281868.","journal-title":"Am Stat Assoc"},{"key":"115_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR: Regression models and life tables (with discussion). J R Stat Soc B. 1972, 34: 187-220.","journal-title":"J R Stat Soc B"},{"key":"115_CR20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","volume":"329","author":"WF Owen","year":"1993","unstructured":"Owen WF, Leu NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. New Engl J Med. 1993, 329: 1001-1006. 10.1056\/NEJM199309303291404.","journal-title":"New Engl J Med"},{"key":"115_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2215\/CJN.01610407","volume":"3","author":"DT Gilbertson","year":"2008","unstructured":"Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ: Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol. 2008, 3: 133-138. 10.2215\/CJN.01610407.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"115_CR22","first-page":"398","volume":"98","author":"G Kadikoylu","year":"2006","unstructured":"Kadikoylu G, Yavasoglu I, Bolaman Z, Senturk T: Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc. 2006, 98 (3): 398-402.","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"115_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1053\/j.ajkd.2008.05.029","volume":"52","author":"E Streja","year":"2008","unstructured":"Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K: Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis. 2008, 52 (4): 727-36. 10.1053\/j.ajkd.2008.05.029.","journal-title":"Am J Kidney Dis"},{"key":"115_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1046\/j.1523-1755.2001.059003883.x","volume":"59","author":"IC van Riemsdijk","year":"2001","unstructured":"van Riemsdijk IC, Baan CC, Loonen EH, Knoop CJ, Navarro Betonico G, Niesters HG, Zietse R, Weimar W: T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. Kidney Int. 2001, 59: 883-892. 10.1046\/j.1523-1755.2001.059003883.x.","journal-title":"Kidney Int"},{"key":"115_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1046\/j.1523-1755.2003.00099.x","volume":"64","author":"G Weiss","year":"2003","unstructured":"Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G: Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int. 2003, 64: 572-578. 10.1046\/j.1523-1755.2003.00099.x.","journal-title":"Kidney Int"},{"key":"115_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0002-9629(15)40626-3","volume":"318","author":"ME Conrad","year":"1999","unstructured":"Conrad ME, Umbreit JN, Moore EG: Iron absorption and transport. Am J Med Sci. 1999, 318: 213-229. 10.1097\/00000441-199910000-00002.","journal-title":"Am J Med Sci"},{"key":"115_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0098-2997(00)00006-6","volume":"22","author":"PT Lieu","year":"2001","unstructured":"Lieu PT, Heiskala M, Peterson PA, Yang Y: The roles of iron in health and disease. Mol Aspects Med. 2001, 22: 1-87. 10.1016\/S0098-2997(00)00006-6.","journal-title":"Mol Aspects Med"},{"key":"115_CR28","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69002.x","volume":"69","author":"P Ponka","year":"1999","unstructured":"Ponka P: Cellular iron metabolism. Kidney Int Suppl. 1999, 69: S2-11. 10.1046\/j.1523-1755.1999.055Suppl.69002.x.","journal-title":"Kidney Int Suppl"},{"key":"115_CR29","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.261708798","volume":"99","author":"PB Walter","year":"2002","unstructured":"Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE, Ames BN: Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci USA. 2002, 99: 2264-2269. 10.1073\/pnas.261708798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"115_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1172\/JCI108489","volume":"58","author":"CA Finch","year":"1976","unstructured":"Finch CA, Miller LR, Inamdar AR, Person R, Seiler K, Mackler B: Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest. 1976, 58: 447-453. 10.1172\/JCI108489.","journal-title":"J Clin Invest"},{"key":"115_CR31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/jn\/120.8.909","volume":"120","author":"WT Willis","year":"1990","unstructured":"Willis WT, Gohil K, Brooks GA, Dallman PR: Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats. J Nutr. 1990, 120: 909-916.","journal-title":"J Nutr"},{"key":"115_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2310\/6650.2001.34044","volume":"49","author":"VE Pollak","year":"2001","unstructured":"Pollak VE, Lorch JA, Means RTJ: Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients. J Investig Med. 2001, 49: 173-183. 10.2310\/6650.2001.34044.","journal-title":"J Investig Med"},{"key":"115_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1053\/j.ajkd.2003.12.029","volume":"43","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, McAllister CJ, Lehn RS, Liu E, Kopple JD: A low serum iron level is a predictor of poor outcome in hemodialysis patients. Am J Kidney Dis. 2004, 43: 671-684. 10.1053\/j.ajkd.2003.12.029.","journal-title":"Am J Kidney Dis"},{"key":"115_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfg390","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F: Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant. 2004, 19: 1-47. 10.1093\/ndt\/gfg390.","journal-title":"Nephrol Dial Transplant"},{"key":"115_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.0894-0959.2004.17359.x","volume":"17","author":"S Fishbane","year":"2004","unstructured":"Fishbane S, Kalantar-Zadeh K, Nissenson AR: Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment. Semin Dial. 2004, 17: 336-341. 10.1111\/j.0894-0959.2004.17359.x.","journal-title":"Semin Dial"},{"key":"115_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1681\/ASN.2006080856","volume":"18","author":"WH Horl","year":"2007","unstructured":"Horl WH: Clinical aspects of iron use in the anemia of kidney disease. J Am Soc Nephrol. 2007, 18: 382-393. 10.1681\/ASN.2006080856.","journal-title":"J Am Soc Nephrol"},{"key":"115_CR37","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1681\/ASN.2005040423","volume":"16","author":"K Kalantar-Zadeh","year":"2005","unstructured":"Kalantar-Zadeh K, Regidor DL, McAllister CJ, Michael B, Warnock DG: Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients. J Am Soc Nephrol. 2005, 16: 3070-3080. 10.1681\/ASN.2005040423.","journal-title":"J Am Soc Nephrol"},{"key":"115_CR38","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V1092029","volume":"10","author":"A Besarab","year":"1999","unstructured":"Besarab A, Frinak S, Yee J: An indistinct balance: the safety and efficacy of parenteral iron therapy. J Am Soc Nephrol. 1999, 10: 2029-2043.","journal-title":"J Am Soc Nephrol"},{"key":"115_CR39","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x","volume":"69","author":"IC Macdougall","year":"1999","unstructured":"Macdougall IC: Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999, 69: S61-S66. 10.1046\/j.1523-1755.1999.055Suppl.69061.x.","journal-title":"Kidney Int Suppl"},{"key":"115_CR40","first-page":"S9","volume-title":"Kidney Int Suppl","author":"R Agarwal","year":"2006","unstructured":"Agarwal R: Overcoming barriers that inhibit proper treatment of anemia. Kidney Int Suppl. 2006, S9-12."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-10-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T22:44:22Z","timestamp":1738968262000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-10-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-10-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,26]]},"article-number":"6"}}